A roundup of personnel changes by medical device, diagnostics and life science companies around the nation:
-
Spectranetics announces retirement of chairman and CEO Emile J. Geisenheimer
Spectranetics Corp. (NSDQ:SPNC) announced that Emile J. Geisenheimer is retiring from his positions as Chairman, President, and Chief Executive Officer, effective November 1, 2010. Mr. Geisenheimer will continue to serve on the Board of Directors. Spectranetics’ Board of Directors has appointed an Executive Committee of the Board to work directly with the Company’s management while it initiates a search for Mr. Geisenheimer’s replacement.
Read more -
Pro-Dex Inc. appoints Harold A. Hurwitz as chief financial officer
Pro-Dex Inc. (NSDQ:PDEX) announced the appointment of Harold A. (“Hal”) Hurwitz as Chief Financial Officer, effective October 6, 2010. Mr. Hurwitz succeeds Jeffrey J. Ritchey who has left the Company.
Read more -
Minnow Medical bolsters management team
Minnow Medical, Inc., a developer of a novel platform technology employing radiofrequency thermoplasty for the treatment of in-stent restenosis and other peripheral vascular conditions, announced the appointment of two veteran medical device executives. Prabodh Mathur has been named chief product development officer and Michael K. Handley has been named vice president of quality, clinical and regulatory affairs.
Read more -
Minnow Medical names Raymond W. Cohen as chief executive officer
Minnow Medical, Inc., a developer of a novel platform technology employing radiofrequency thermoplasty for the treatment of in-stent restenosis and other peripheral vascular conditions, announced that veteran medical technology executive Raymond W. Cohen has been named chief executive officer and a member of the board of directors.
Read more -
DiFUSION Technologies adds accomplished senior management team
DiFUSION Technologies, Inc. announced the company has reached another major milestone with the addition of talented industry veterans to its management team roster.
Read more -
Life Technologies names chief medical officer
Life Technologies Corporation (NSDQ:LIFE), a provider of innovative life science solutions, has named physician and clinical geneticist Dr. Paul R. Billings as Chief Medical Officer, a newly created position aimed at improving patient care through expanding the use of medically relevant genomic technologies in clinical settings.
Read more -
Tom Allen named chief executive officer of Aubrey Group
The Board of Directors of Aubrey Group is happy to announce that Tom Allen has been named Chief Executive Officer (CEO). Tom brings more than 30 years experience in the medical device and life sciences industry in a range of positions including General Management, Sales and Marketing, Manufacturing, Mergers, and International Manufacturing.
Read more -
Spectral Molecular Imaging announces the appointment of Dr. Sam Raz as vice president for international business development
Spectral Molecular Imaging, a wholly-owned subsidiary of Cascade Technologies Corp. (OTC:CSDT), announced that Dr. Sam Raz has been appointed VP for International Business Development at SMI.
Read more -
Celera announces resignation of chief financial officer
Celera Corporation (NSDQ:CRA) announced that Ugo DeBlasi, Senior Vice President and Chief Financial Officer, has decided to leave his position to pursue employment opportunities closer to his family in Connecticut. Mr. DeBlasi has served as the Company’s CFO since April 2009, and during this time has commuted to the Company from his primary residence in Connecticut. Mr. DeBlasi has indicated he will stay at Celera until November 19, 2010, to assist the Company through its third quarter reporting obligations and transitioning of his responsibilities.
Read more -
David P. Lang appointed vice president of CryoLife International Inc.
CryoLife Inc. (NYSE:CRY), an implantable biological medical device and cardiovascular tissue processing company, announced that it has appointed David P. Lang as vice president of market development for CryoLife International Inc. In this newly created position, Mr. Lang will have responsibility for coordinating and developing the international marketing and distribution strategies for PerClot, a novel hemostatic agent that the Company recently licensed from Starch Medical Inc. Mr. Lang will report to Gerald B. Seery, senior vice president sales and marketing and president, CryoLife International, Inc.
Read more -
TranS1 Inc. Announces Promotion of Stephen D. Ainsworth, Ph.D. to Vice President of Research and Development
TranS1 Inc. (NSDQ:TSON), a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region, is pleased to announce the promotion of Stephen Ainsworth, Ph.D. to Vice President of Research and Development.
Read more -
Former FDA 510(k) director Heather Rosecrans joins Greenleaf Health LLC
Greenleaf Health LLC announced that Heather Rosecrans, former Director of the 510(k) Pre-Market Notification Staff at the Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) has joined the firm. Greenleaf Health is a full service regulatory consulting firm that provides strategic guidance to companies regulated by the FDA that are developing innovative solutions to pressing public health challenges around the globe.
Read more -
Millstone Medical Outsourcing makes strategic hires in Memphis
Millstone Medical Outsourcing announced that the company hired three new professionals to support operations in the Memphis, TN, facility. Perry C. Rothrock, III, MD, was hired as a consultant to serve as Medical Director. His role will be to ensure the integrity of all processes involving Millstone’s bone and tissue bank. Wade A. Hanes, a former Master Chief in the United States Navy, was hired as Second Shift Operations Manager. Marcie L. Malin will serve as Assistant Program Manager and will lend support to help launch and maintain customer programs.
Read more -
Leading perinatologist and stem cell advocate Dr. Sanford M. Lederman, MD, appointed to AmStem scientific and medical board of advisors
AmStem Corp. (Pink Sheets:AMST), a leading provider of biotherapeutic and cosmetic stem cell products, stem cell collection and storage expertise and access to nanotechnology vital to stem cell research, announced the appointment of renowned perinatologist Dr. Sanford M. Lederman, MD, to its Scientific and Medical Board of Advisors (SAMBA).
Read more -
ClinTec strengthens U.S. operations with the appointment of new executive vice president, Dr. Dianne Kikta
UK-based global Clinical Research Organisation (CRO), ClinTec International has further established its US presence with the appointment of new Executive Vice President, Dr Dianne Kikta.
Read more -
Aethlon Medical appoints Jim Frakes as chief financial officer
Aethlon Medical, Inc. (OTC:AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced that it has appointed Jim Frakes, currently serving as Senior Vice President-Finance, as Chief Financial Officer.
Read more -
Predictive Biosciences appoints new members to leadership team (PDF)
Predictive Biosciences, a fully‐integrated developer of novel
molecular diagnostic cancer assays and a provider of anatomic pathology products and services, today
announced the expansion of the company’s leadership team with the appointment of Thomas M. Ross
as chief commercial officer, and Randal Vader as vice president of clinical and regulatory affairs.
Read more (PDF) -
Capitol Scientific hires executive VP of business development
Capitol Scientific, a rapidly growing laboratory supply distributor based in Austin, TX, appointed Michael Elam to the newly created position of Executive Vice-President of Business Development. In a position demanded by Capitol Scientific’s recent significant growth in both revenue and personnel, Michael will drive customer satisfaction and continue to expand Capitol’s involvement in local, national and international markets.
Read more
